The House passage of its FY 2020 appropriations “minibus” funding bill Wednesday supports and sustains important federal HIV and public health programs and offers essential support for the administration’s initiative to end the American HIV epidemic in fiscal year 2020.
The Senate Health, Education, Labor and Pensions Committee hearing today on the Lower Health Care Costs Act provides a valuable opportunity for lawmakers to address challenges compromising access to and uptake of vaccines that are among our most important public health tools.
Uganda health officials’ confirmation today of Ebola virus among family members who travelled from the Democratic Republic of Congo brings with it the realization of a concern that has been noted since the August 2018 recognition of the current outbreak.
The U.S. Preventive Services Task Force’s final “A” grade recommendation for pre-exposure prophylaxis (PrEP) for HIV represents a critical milestone for improving access to PrEP for individuals with health insurance coverage and to advancing the administration’s initiative to end HIV as an epidemic.
The Department of Health and Human Services’ announcement Wednesday that it will halt funding for research involving the use of human fetal tissue conducted within the National Institutes of Health, and review funding for research at extramural research universities with potential new restrictions, will significantly imperil our most promising strategies to develop a cure for HIV and other life-threatening diseases, while soundly undermining the administration’s stated commitment to ending the HIV epidemic.
HIVMA, IDSA, PIDS, National Coalition of STD Directors, and Treatment Action Group respond to HHS request for information during development of the first Federal STD Action Plan, highlight high costs and key barriers to prevention, treatment and care.
The Ebola outbreak in the Democratic Republic of Congo’s North Kivu province remains uncontrolled despite heroic efforts on the part of international and local responders.
The administration’s proposals to weaken protections for transgender individuals that improve their access to health care, housing and shelter services are discriminatory, destructive and pose significant, threats to the president’s stated goal of ending HIV as an epidemic in the U.S
Thank you for the opportunity to submit testimony for the record on behalf of the HIV Medicine Association (HIVMA) regarding the role of drug pricing and associated drug costs as barriers to people at higher risk for HIV accessing Pre-Exposure Prophylaxis (PrEP)
The final rule released by the U.S. Department of Health and Human Services Thursday affirming support for health care providers who deny care and treatment based on their religious beliefs reinforces stigma and discrimination, with clear negative impacts to the administration’s initiative to End the HIV Epidemic within the next decade.
The House Appropriations Labor-Health and Human Services subcommittee advanced a bill Tuesday that would provide essential support for the administration’s initiative to end the American HIV epidemic in the next 10 years.
Citing the spread of infections linked to rising rates of opioid use across the country including HIV, viral hepatitis, skin and soft tissue infections, bone and joint infections and endocarditis